Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Current Leases (2020 - 2025)

Historic Current Leases for Anaptysbio (ANAB) over the last 6 years, with Q3 2025 value amounting to $2.0 million.

  • Anaptysbio's Current Leases rose 810.81% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 810.81%. This contributed to the annual value of $1.9 million for FY2024, which is 832.86% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Current Leases is $2.0 million, which was up 810.81% from $2.0 million recorded in Q2 2025.
  • Anaptysbio's 5-year Current Leases high stood at $2.0 million for Q3 2025, and its period low was $555000.0 during Q2 2021.
  • Moreover, its 5-year median value for Current Leases was $1.7 million (2023), whereas its average is $1.7 million.
  • Per our database at Business Quant, Anaptysbio's Current Leases surged by 34005.85% in 2021 and then skyrocketed by 810.81% in 2025.
  • Quarter analysis of 5 years shows Anaptysbio's Current Leases stood at $1.5 million in 2021, then increased by 8.77% to $1.6 million in 2022, then increased by 8.55% to $1.8 million in 2023, then grew by 8.33% to $1.9 million in 2024, then rose by 5.97% to $2.0 million in 2025.
  • Its Current Leases was $2.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.0 million in Q1 2025.